Intellectual Property

Aramis benefits from a portfolio of intellectual property developed over more than 20 years, acquired from Medicago, including patents and patent applications, trademarks, copyrights and strategic licenses. This asset provides a solid foundation for the development and commercialization of innovative biosolutions.

The company has also ensured the transfer of the vast majority of the know-how associated with the platform through the hiring of former Medicago employees. This expertise not only preserves critical knowledge and trade secrets, but also ensures exceptional technological continuity.

Building on this heritage, Aramis continues to innovate and has already generated new IP assets through major enhancements to several components of its technology, strengthening its competitive advantage and leadership position in the field.